SF
AMRX icon

Synovus Financial’s Amneal Pharmaceuticals AMRX Stock Holding History

Synovus Financial’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,222
Closed -$43.1K – 825
2023
Q3 		$43.1K Hold
10,222
– – ﹤0.01% 831
2023
Q2 		$31.7K Hold
10,222
– – ﹤0.01% 833
2023
Q1 		$14.2K Hold
10,222
– – ﹤0.01% 823
2022
Q4 		$20.3K Sell
10,222
-5,000
-33% -$11.2K ﹤0.01% 853
2022
Q3 		$31K Hold
15,222
– – ﹤0.01% 836
2022
Q2 		$48K Hold
15,222
– – ﹤0.01% 832
2022
Q1 		$63K Hold
15,222
– – ﹤0.01% 835
2021
Q4 		$73K Hold
15,222
– – ﹤0.01% 849
2021
Q3 		$81K Hold
15,222
– – ﹤0.01% 828
2021
Q2 		$78K Buy
+15,222
New +$86.5K ﹤0.01% 826

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return